U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C31H33N3O6S
Molecular Weight 575.675
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ZAFIRLUKAST

SMILES

COC1=C(CC2=CN(C)C3=C2C=C(NC(=O)OC4CCCC4)C=C3)C=CC(=C1)C(=O)NS(=O)(=O)C5=C(C)C=CC=C5

InChI

InChIKey=YEEZWCHGZNKEEK-UHFFFAOYSA-N
InChI=1S/C31H33N3O6S/c1-20-8-4-7-11-29(20)41(37,38)33-30(35)22-13-12-21(28(17-22)39-3)16-23-19-34(2)27-15-14-24(18-26(23)27)32-31(36)40-25-9-5-6-10-25/h4,7-8,11-15,17-19,25H,5-6,9-10,16H2,1-3H3,(H,32,36)(H,33,35)

HIDE SMILES / InChI

Molecular Formula C31H33N3O6S
Molecular Weight 575.675
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 17:43:31 UTC 2023
Edited
by admin
on Sat Dec 16 17:43:31 UTC 2023
Record UNII
XZ629S5L50
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ZAFIRLUKAST
INN   JAN   MART.   MI   ORANGE BOOK   USAN   VANDF   WHO-DD  
USAN   INN  
Official Name English
ZAFIRLUKAST [MART.]
Common Name English
Cyclopentyl 3-[2-methoxy-4-[(O-tolylsulfonyl)carbamoyl]benzyl]-1-methylindole-5-carbamate
Common Name English
ZAFIRLUKAST [USAN]
Common Name English
ICI-204,219
Common Name English
ICI 204,219
Code English
ICI-204219
Code English
Zafirlukast [WHO-DD]
Common Name English
ZAFIRLUKAST [MI]
Common Name English
ACCOLATE
Brand Name English
ZAFIRLUKAST [VANDF]
Common Name English
ZAFIRLUKAST [ORANGE BOOK]
Common Name English
zafirlukast [INN]
Common Name English
ZAFIRLUKAST [JAN]
Common Name English
CARBAMIC ACID, (3-((2-METHOXY-4-(((2-METHYLPHENYL)SULFONYL)AMINO)CARBONYL)PHENYL)METHYL)-1-METHYL-1H-INDOL-5-YL)-, CYCLOPENTYL ESTER
Common Name English
Classification Tree Code System Code
NDF-RT N0000175777
Created by admin on Sat Dec 16 17:43:32 UTC 2023 , Edited by admin on Sat Dec 16 17:43:32 UTC 2023
NDF-RT N0000000083
Created by admin on Sat Dec 16 17:43:32 UTC 2023 , Edited by admin on Sat Dec 16 17:43:32 UTC 2023
NCI_THESAURUS C29712
Created by admin on Sat Dec 16 17:43:32 UTC 2023 , Edited by admin on Sat Dec 16 17:43:32 UTC 2023
LIVERTOX NBK547915
Created by admin on Sat Dec 16 17:43:32 UTC 2023 , Edited by admin on Sat Dec 16 17:43:32 UTC 2023
WHO-ATC R03DC01
Created by admin on Sat Dec 16 17:43:32 UTC 2023 , Edited by admin on Sat Dec 16 17:43:32 UTC 2023
WHO-VATC QR03DC01
Created by admin on Sat Dec 16 17:43:32 UTC 2023 , Edited by admin on Sat Dec 16 17:43:32 UTC 2023
Code System Code Type Description
SMS_ID
100000091929
Created by admin on Sat Dec 16 17:43:32 UTC 2023 , Edited by admin on Sat Dec 16 17:43:32 UTC 2023
PRIMARY
CAS
107753-78-6
Created by admin on Sat Dec 16 17:43:32 UTC 2023 , Edited by admin on Sat Dec 16 17:43:32 UTC 2023
PRIMARY
USAN
GG-93
Created by admin on Sat Dec 16 17:43:32 UTC 2023 , Edited by admin on Sat Dec 16 17:43:32 UTC 2023
PRIMARY
MERCK INDEX
m11576
Created by admin on Sat Dec 16 17:43:32 UTC 2023 , Edited by admin on Sat Dec 16 17:43:32 UTC 2023
PRIMARY Merck Index
INN
7244
Created by admin on Sat Dec 16 17:43:32 UTC 2023 , Edited by admin on Sat Dec 16 17:43:32 UTC 2023
PRIMARY
FDA UNII
XZ629S5L50
Created by admin on Sat Dec 16 17:43:32 UTC 2023 , Edited by admin on Sat Dec 16 17:43:32 UTC 2023
PRIMARY
EVMPD
SUB00128MIG
Created by admin on Sat Dec 16 17:43:32 UTC 2023 , Edited by admin on Sat Dec 16 17:43:32 UTC 2023
PRIMARY
ChEMBL
CHEMBL603
Created by admin on Sat Dec 16 17:43:32 UTC 2023 , Edited by admin on Sat Dec 16 17:43:32 UTC 2023
PRIMARY
NCI_THESAURUS
C47785
Created by admin on Sat Dec 16 17:43:32 UTC 2023 , Edited by admin on Sat Dec 16 17:43:32 UTC 2023
PRIMARY
PUBCHEM
5717
Created by admin on Sat Dec 16 17:43:32 UTC 2023 , Edited by admin on Sat Dec 16 17:43:32 UTC 2023
PRIMARY
IUPHAR
3322
Created by admin on Sat Dec 16 17:43:32 UTC 2023 , Edited by admin on Sat Dec 16 17:43:32 UTC 2023
PRIMARY
DRUG BANK
DB00549
Created by admin on Sat Dec 16 17:43:32 UTC 2023 , Edited by admin on Sat Dec 16 17:43:32 UTC 2023
PRIMARY
EPA CompTox
DTXSID5023746
Created by admin on Sat Dec 16 17:43:32 UTC 2023 , Edited by admin on Sat Dec 16 17:43:32 UTC 2023
PRIMARY
LACTMED
Zafirlukast
Created by admin on Sat Dec 16 17:43:32 UTC 2023 , Edited by admin on Sat Dec 16 17:43:32 UTC 2023
PRIMARY
WIKIPEDIA
ZAFIRLUKAST
Created by admin on Sat Dec 16 17:43:32 UTC 2023 , Edited by admin on Sat Dec 16 17:43:32 UTC 2023
PRIMARY
DRUG CENTRAL
2855
Created by admin on Sat Dec 16 17:43:32 UTC 2023 , Edited by admin on Sat Dec 16 17:43:32 UTC 2023
PRIMARY
MESH
C062735
Created by admin on Sat Dec 16 17:43:32 UTC 2023 , Edited by admin on Sat Dec 16 17:43:32 UTC 2023
PRIMARY
RXCUI
114970
Created by admin on Sat Dec 16 17:43:32 UTC 2023 , Edited by admin on Sat Dec 16 17:43:32 UTC 2023
PRIMARY RxNorm
DAILYMED
XZ629S5L50
Created by admin on Sat Dec 16 17:43:32 UTC 2023 , Edited by admin on Sat Dec 16 17:43:32 UTC 2023
PRIMARY
CHEBI
10100
Created by admin on Sat Dec 16 17:43:32 UTC 2023 , Edited by admin on Sat Dec 16 17:43:32 UTC 2023
PRIMARY
NDF-RT
N0000185504
Created by admin on Sat Dec 16 17:43:32 UTC 2023 , Edited by admin on Sat Dec 16 17:43:32 UTC 2023
PRIMARY Cytochrome P450 2C9 Inhibitors [MoA]
Related Record Type Details
BINDER->LIGAND
BINDING
TARGET -> INHIBITOR
METABOLIC ENZYME -> SUBSTRATE
MAJOR
METABOLIC ENZYME -> INHIBITOR
in vitro studies utilizing human liver microsomes show that zafirlukast inhibits the cytochrome P450 CYP3A4 and CYP2C9 isoenzymes at concentrations close to the clinically achieved total plasma concentrations.
METABOLIC ENZYME -> INHIBITOR
in vitro studies utilizing human liver microsomes show that zafirlukast inhibits the cytochrome P450 CYP3A4 and CYP2C9 isoenzymes at concentrations close to the clinically achieved total plasma concentrations
Related Record Type Details
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Route of Elimination PHARMACOKINETIC
Volume of Distribution PHARMACOKINETIC
Cmax PHARMACOKINETIC Populations
PHARMACOKINETIC
Route of Elimination PHARMACOKINETIC
Volume of Distribution PHARMACOKINETIC
Biological Half-life PHARMACOKINETIC
Cmax PHARMACOKINETIC Populations
PHARMACOKINETIC
Tmax PHARMACOKINETIC
Onset of Action PHARMACOKINETIC